Staci L. Julie is the Senior Vice President and Chief IP Counsel for Teva Pharmaceuticals, and has been in this role since 2013. Ms. Julie and her global team are responsible for all of Teva’s IP and regulatory law support for its specialty, generic, biologic/biosimilar, and API products. Ms. Julie has been with Teva since 2004, previously serving in various IP roles. Prior to joining Teva, Ms. Julie was an associate at Fish & Neave. In 2015, Ms. Julie was named an Emerging Pharma Leader by Pharm Exec magazine. Ms. Julie received a BA in Chemistry from the University of Delaware and a JD from Georgetown University Law Center.